How does Medicare cover GLP‑1 medicines like Ozempic, Wegovy and Zepbound?
Which part of Medicare pays, which uses a drug plan can cover, what you pay in 2026 and 2027, and how to challenge a Part D denial, step by step. From CMS and Medicare.gov documents.
Written for the United States, from US sources.
Medicare covers GLP‑1 medicines through Part D drug plans for approved medical uses, such as type 2 diabetes (Ozempic), heart risk (Wegovy) or sleep apnea (Zepbound). Federal law bars Part D from covering them for weight loss alone. The temporary $50 Medicare GLP‑1 Bridge covers some for weight through 2027. Each plan sets its own rules.
Key takeaways
- Medicare drug plans can cover Ozempic, Wegovy or Zepbound for approved medical uses such as type 2 diabetes, heart risk or sleep apnea, but federal law bars weight-loss-only use.1,3
- The Medicare GLP‑1 Bridge covers Wegovy, Foundayo and the Zepbound KwikPen for weight at $50 a month, outside Part D, through December 31, 2027.7,1
- The yearly cap on what you pay for Part D drugs is $2,100 in 2026 and rises to $2,400 in 2027.11
- Medicare’s negotiated price for Ozempic, Rybelsus and Wegovy from January 1, 2027, is $274 for a 30-day supply, against a 2024 list price of $959.13
- A Part D plan must answer a standard coverage request within 72 hours, and you have 65 days from a denial notice to ask the plan to look again.16,19
- Every Medicare drug plan has its own drug list and rules. Check your own plan’s list; this page describes the federal rules all plans work within.
- This page explains how coverage works. It can’t tell you whether you qualify: your plan, Medicare and your prescriber decide that.
- We don’t recommend or rank any plan or insurer. These medicines need a prescription and carry real risks: see our side effects guide.
On this page
- Which part of Medicare pays?
- Which uses can a drug plan cover?
- Where does the $50 Bridge fit?
- What will you pay in 2026 and 2027?
- What do the drug list marks mean?
- How do you ask for a coverage decision?
- What are the 5 levels of appeal?
- What can you check at open enrollment?
- Questions people ask
- How we researched this
- Sources
Which part of Medicare pays for GLP‑1 medicines?
Part D, the drug coverage you get from a private plan, pays for GLP‑1 medicines you inject or swallow at home, not Part B.5,4
Part B is the medical part of Medicare. It covers drugs you wouldn’t usually give yourself, such as those given in a doctor’s office or hospital clinic.5 Weekly pens and daily pills are taken at home, so they usually fall under Part D.5
You can get Part D in one of 2 ways:4
- A separate drug plan added to Original Medicare (Parts A and B, run by the federal government).
- A Medicare Advantage plan (Part C), which bundles Parts A and B and usually Part D. If your Advantage plan has no drug coverage, in most cases you can’t add a separate drug plan.
Either way, the plan follows Medicare’s rules but chooses its own drugs and costs.4 Part B does pay for weight counseling from your primary care provider if your BMI (body mass index, a measure of weight for height) is 30 or more. It costs nothing if the provider accepts Medicare’s rates.6
Which uses of a GLP‑1 can a Medicare drug plan cover?
A Part D plan can cover a GLP‑1 for an approved use, such as diabetes, heart risk or sleep apnea, but not weight loss alone.1,3
Federal law lets drug programs exclude medicines “when used for anorexia, weight loss, or weight gain”.2 Part D’s definition of a covered drug leaves out those uses.3 KFF, a health-policy research group, says Medicare “has been prohibited by law from covering medications when used specifically for weight loss”.1
The ban follows the reason for the prescription, not the medicine.3 So a plan can cover the same medicine for another use on its FDA label (the official prescribing information).1
| Why it is prescribed | Medicine and its US label | Who can pay in Medicare |
|---|---|---|
| Type 2 diabetes | Ozempic: blood sugar, and lowering heart and kidney risk in type 2 diabetes22 | Your Part D plan1 |
| Heart risk | Wegovy: lowering heart attack, stroke and heart death risk in adults with heart disease and obesity or overweight23 | Your Part D plan1 |
| Sleep apnea | Zepbound: moderate to severe obstructive sleep apnea in adults with obesity24 | Your Part D plan1 |
| MASH (fatty liver with scarring) | Wegovy: MASH with moderate to advanced scarring, without cirrhosis23 | Your Part D plan, which “may already cover” it7 |
| Weight loss alone | Wegovy, Zepbound KwikPen, Foundayo7 | Only the GLP‑1 Bridge, at $50 a month, through 20277,1 |
Plans can cover these uses, and each sets its own rules. Sources: US labels; KFF, May 11, 2026; Medicare.gov fact sheet, June 2026.
Each plan picks its own drugs and may ask for proof of the use first.4,15 From January 1, 2027, the law requires every Part D plan to put Ozempic, Rybelsus and Wegovy on its drug list, because Medicare negotiated their price.13 That still covers only the uses above, not weight loss alone.3 More detail: Wegovy for heart and fatty liver and Zepbound for sleep apnea.
- Stomach effects. In the diabetes trials, 16 to 20 in 100 people on Ozempic 0.5 mg or 1 mg felt sick (nausea), against 6 in 100 on a placebo (dummy injection).22 About 44 in 100 on Wegovy 2.4 mg felt sick, against about 16 in 100 on placebo;23 about 25 to 29 in 100 on Zepbound, against about 8 in 100.24
- Gallstones were reported in 16 in 1,000 people on Wegovy injection, against 7 in 1,000 on placebo;23 11 in 1,000 on Zepbound, against 10 in 1,000.24
- Pancreatitis (an inflamed pancreas): severe stomach pain that won’t go away and may spread to the back. The labels say to stop the medicine if it is suspected.22,23,24
- Thyroid warning. The labels carry a boxed warning: these medicines are not for people with a personal or family history of medullary thyroid cancer (MTC) or MEN 2, a rare inherited condition that causes gland tumors.22,23,24
- Low blood sugar. The risk rises when a GLP‑1 is taken with insulin or a sulfonylurea, an older type of diabetes pill.22
- Dehydration from vomiting or diarrhea can harm the kidneys. Tell the team before any surgery or sedation, because a slower-emptying stomach raises the risk of breathing in food or fluid.23,24
Where does the $50 Medicare GLP‑1 Bridge fit in?
The Bridge is a separate, temporary Medicare program for weight use only, so it sits outside your Part D plan and its rules.9,7
It covers Foundayo, Wegovy injection or tablets, and the Zepbound KwikPen at $50 a month, “no matter your income level”.7 Single-dose Zepbound pens and vials are not covered.7 It runs through December 31, 2027; KFF says it is uncertain what happens after that.1
You need Part D to use it, through a separate drug plan or a Medicare health plan with drug coverage.7 Because it sits outside Part D, 4 plan rules don’t apply to the $50:9,7
- the Part D deductible;
- the yearly out-of-pocket cap, which the $50 doesn’t count toward;
- Extra Help, the low-income subsidy;
- the Medicare Prescription Payment Plan.
People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease can’t use the Bridge. Medicare tells them to contact their drug plan, which “may already cover” a GLP‑1.7 If your plan has paid for a GLP‑1 “for any reason”, you keep getting it through the plan.7 The BMI rules and the steps are in the Medicare GLP‑1 Bridge explained and who qualifies for the Bridge.
What will you pay for a GLP‑1 through Part D in 2026 and 2027?
Your plan’s deductible and copays apply until your yearly costs reach a cap, which is $2,100 in 2026 and $2,400 in 2027.10,11
A Part D year has 3 stages, says Medicare:10
- Deductible: you pay the full cost until you reach it. No plan’s deductible can be above $615 in 2026 or $700 in 2027; some plans have none.
- Initial coverage: Medicare says you pay 25% of the cost (coinsurance), until your spending reaches the cap. Your plan’s drug list sorts drugs into tiers (price levels), and each tier has its own copay or coinsurance.27
- Catastrophic coverage: after the cap, you pay nothing for covered Part D drugs for the rest of the calendar year.
The 2027 negotiated price. Medicare negotiated a price for Ozempic, Rybelsus and Wegovy; the law calls it the maximum fair price. From January 1, 2027, it is $274 for a 30-day supply.13 The 2024 list price was $959, so that is 71% lower.13 CMS spreads it across strengths, so a box can differ: 4 Wegovy 2.4 mg pens are priced at $385.63.13,14
$274 is the price drug plans and pharmacies work from, not your copay.13 What you pay still depends on your plan’s tier, deductible and the cap.27,10 It doesn’t lift the weight-loss ban.3 The Bridge uses a separate $245 monthly net price agreed with the makers.1 More in Ozempic’s $274 Medicare price: what you will actually pay.
Help with costs. With Extra Help, a plan can charge at most $12.65 for a brand-name drug in 2026, and $14.40 in 2027. Some people pay less.11 You get Extra Help automatically with Medicaid, a Medicare Savings Program or SSI (Supplemental Security Income).10 The Medicare Prescription Payment Plan spreads your costs across the year, but it “doesn’t save you money”.10
Pick Medicare’s Bridge, insurance or self-pay, a medicine and a dose plan. No sign-up.
What do the marks next to a GLP‑1 on a plan’s drug list mean?
They are the plan’s rules for that drug: prior authorization, step therapy or a quantity limit, and each one can be challenged with an exception.15
- Prior authorization (PA): approval you or your prescriber must get before the plan pays. Plans also use it when they cover a drug for some conditions but not others.15
- Step therapy (ST): you must try a cheaper drug on the list first.15
- Quantity limit (QL): a cap on how much the plan covers over a set time.15
A new plan may give you a transition fill. That is a one-time, 30-day supply of a drug you already take that the plan doesn’t cover, or covers only with PA or step therapy.15 From January 1, 2027, plans may process PA requests electronically.15 How to read the codes on any plan: reading your drug list and asking for an exception.
How do you ask a Part D plan to cover a GLP‑1?
You or your prescriber ask the plan for a coverage determination; a standard answer is due within 72 hours, and an urgent one within 24.16
A coverage determination is any plan decision about whether it pays for a drug, at what cost, and under which rules.16 You, your prescriber or your representative can ask by phone or in writing.16 Medicare offers a “Model Coverage Determination Request” form.18
An exception is a request to bend the plan’s rules. There are 2 kinds:17
- Formulary exception: cover a drug that isn’t on the list, or waive a PA, step therapy or quantity limit.
- Tiering exception: charge a non-preferred drug at a preferred tier’s cost.
Every exception needs a supporting statement from your prescriber. It must say the plan’s alternatives would work less well, cause harm, or both.17,15 The 72-hour or 24-hour clock starts only when the plan gets that statement.16
An urgent (expedited) request is for when waiting could seriously harm your life, health or ability to regain function.18 An exception can’t open the weight-loss ban, because that use isn’t a covered Part D drug at all.3
What are the 5 levels of a Part D appeal?
If the plan says no, you have 65 days to ask it to look again; 4 more levels follow, each with a 60-day deadline.18,19
- 1Redetermination by your plan. Ask within 65 days of the date on the denial notice. The plan decides within 7 days, or 72 hours if urgent.19,18
- 2Independent Review Entity (IRE). An outside reviewer working for Medicare. Ask within 60 days of the plan’s decision; the same 7-day and 72-hour limits apply.18,26
- 3Office of Medicare Hearings and Appeals. An administrative law judge or attorney adjudicator. Ask within 60 days; in 2026 the amount at stake must be at least $200.18,20
- 4Medicare Appeals Council. Ask within 60 days of the hearing decision.18
- 5Federal district court. Ask within 60 days of the Council’s decision; in 2026 the amount must be at least $1,960.18,20
Each decision letter tells you how to go to the next level.18 If you miss a deadline, you must give a reason for filing late.18 Include your Medicare Number, the drug, why you disagree, and your prescriber’s statement.18
Bridge denials work differently. CMS tells prescribers who think a Bridge denial was wrong to resubmit the prior authorization for re-review.8 We found no separate appeal process described in CMS’s Bridge documents.8,9,7 For employer, Marketplace and Medicaid plans, see how GLP‑1 appeals work and prior authorization, step by step.
What can you check during Medicare open enrollment?
From October 15 to December 7 you can switch drug or Advantage plans, and the new plan starts on January 1.21
This year that window runs October 15 to December 7, 2026, for coverage from January 1, 2027.21 The plan must get your request by December 7.21 In a Medicare Advantage plan, you get one more chance from January 1 to March 31: switch plans or return to Original Medicare.21
Medicare says to check that a plan covers your prescriptions.21 For a GLP‑1, look for these:
- Is your medicine on the plan’s list, and what is its copay or coinsurance?4,10
- Does it carry PA, step therapy or a quantity limit?15
- What is the deductible? It can be up to $700 in 2027.10
- Is your pharmacy in the plan’s network, and what are the premium and the estimated yearly drug cost?21
The Bridge doesn’t depend on which plan you pick. You need to keep Part D, and some plan types are excluded, such as PACE (an all-in-one care program for frail older adults).7 Your State Health Insurance Assistance Program (SHIP) gives free, local help comparing plans.4 Step by step: how to check a Part D plan covers Ozempic, Wegovy or Zepbound.
Questions people ask
Does Medicare cover Ozempic?
Yes, a Part D plan can cover Ozempic for its approved uses in type 2 diabetes, if it is on the plan’s drug list. Medicare can’t cover it for weight loss, and the GLP‑1 Bridge doesn’t include Ozempic.22,1,7
Does Medicare cover Wegovy?
A Part D plan can cover Wegovy to lower heart risk in people with heart disease, or for MASH. For weight alone, only the GLP‑1 Bridge covers it, at $50 a month through December 31, 2027.1,7
Does Medicare cover Zepbound?
A Part D plan can cover Zepbound for moderate to severe sleep apnea in adults with obesity. For weight alone, the Bridge covers only the Zepbound KwikPen, not vials or single-dose pens.1,24,7
Will Ozempic cost $274 on Medicare in 2027?
No. $274 for a 30-day supply is the negotiated price that plans and pharmacies work from, from January 1, 2027. Your own cost depends on your plan’s copay or coinsurance, its deductible and the $2,400 yearly cap.13,10
How long do I have to appeal a Part D denial?
65 days from the date on the plan’s denial notice to ask for a redetermination. Each later level has a 60-day deadline from the previous decision.19,18
Does the $50 Bridge copay count toward the Part D cap?
No. The Bridge runs outside Part D, so the $50 doesn’t count toward your yearly out-of-pocket cap and the Part D deductible doesn’t apply.9,7
How we researched this
On October 14, 2026, we read CMS’s 2026 and 2027 rate announcements and its 2027 negotiated-price documents. We also read its Bridge documents.11,12,13,14,7,8,9 Appeal rules come from CMS and Medicare.gov pages, federal regulations and the Federal Register.16,18,20,26
Medicare.gov’s appeals page still shows 2024 dollar amounts, so we used the 2026 figures from the Federal Register.18,20 We left out any estimate of a copay at the $274 price: no CMS document we found shows one.
Before you move on
- Find out why your GLP‑1 is prescribed: weight, diabetes, heart, sleep apnea or MASH.
- Check your own plan’s drug list for the medicine, its tier and any PA, ST or QL mark.
- Note open enrollment: October 15 to December 7, 2026.
- If denied, ask your prescriber for a supporting statement and note the 65-day rule.
- For weight use, ask about the Bridge, which ends December 31, 2027.
More on insurance
The monthly US update
An independent guide to GLP‑1 medicines. We don’t sell medicines, take drug-company money, earn commissions or link to any provider. Once a month: FDA approvals and warnings, Medicare and Medicaid changes, and makers’ price changes. How we write
Sources
- KFF. What to know about the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge. May 11, 2026. Link
- 42 U.S. Code § 1396r-8(d)(2)(A): drugs that may be excluded include “agents when used for anorexia, weight loss, or weight gain”. Legal Information Institute, Cornell Law School. Link
- 42 U.S. Code § 1395w-102(e)(2)(A): a covered Part D drug “does not include drugs or classes of drugs, or their medical uses, which may be excluded” under § 1396r-8(d)(2). Legal Information Institute, Cornell Law School. Link
- Medicare.gov. Drug coverage basics (two ways to get drug coverage; SHIP counseling; 1-800-MEDICARE). Checked Oct 14, 2026. Link
- Medicare.gov. Prescription drugs (outpatient): what Part B covers. Checked Oct 14, 2026. Link
- Medicare.gov. Obesity behavioral therapy (Part B). Checked Oct 14, 2026. Link
- Medicare.gov. Medicare GLP-1 Bridge: GLP-1 drugs for $50 a month (fact sheet). CMS Product No. 12234, June 2026. Link
- CMS. Medicare GLP-1 Bridge: information for prescribers. CMS Product No. 12235, June 2026. Link
- CMS. Medicare GLP-1 Bridge (program page and FAQs). Page last modified July 13, 2026. Link
- Medicare.gov. How much does Medicare drug coverage cost? (deductible, coverage stages, Extra Help, Medicare Prescription Payment Plan). Checked Oct 14, 2026. Link
- CMS. Announcement of Calendar Year 2027 Medicare Advantage capitation rates and Part C and Part D payment policies, Table V-2 (Part D benefit parameters). April 6, 2026. Link
- CMS. Announcement of Calendar Year 2026 Medicare Advantage capitation rates and Part C and Part D payment policies, Table V-2. April 7, 2025. Link
- CMS. Medicare Drug Price Negotiation Program: negotiated prices for initial price applicability year 2027 (fact sheet). November 2025. Link
- CMS. Selected drug list and negotiated prices (maximum fair prices) data file, semaglutide rows. Data as of September 21, 2026. Link
- Medicare.gov. Drug plan rules (prior authorization, step therapy, quantity limits, exceptions, transition fills). Checked Oct 14, 2026. Link
- CMS. Coverage determinations (Part D). Page last modified September 10, 2024. Link
- CMS. Exceptions (Part D). Page last modified September 10, 2024. Link
- Medicare.gov. Appeals in a Medicare drug plan (5 levels, deadlines, decision times). Checked Oct 14, 2026. Link
- CMS. Redetermination by the Part D plan sponsor. Page last modified January 7, 2025. Link
- CMS. Medicare appeals: adjustment to the amount in controversy threshold amounts for calendar year 2026. Federal Register, December 4, 2025. Link
- Medicare.gov. Joining a plan (Open Enrollment and Medicare Advantage Open Enrollment dates). Checked Oct 14, 2026. Link
- Novo Nordisk. Ozempic (semaglutide) injection: US prescribing information. Revised 05/2026. Link
- Novo Nordisk. Wegovy (semaglutide) injection and tablets: US prescribing information. Revised 06/2026. Link
- Eli Lilly. Zepbound (tirzepatide): US prescribing information. Revised 8/2026. Link
- Poison Control (National Capital Poison Center). Poison help line 1-800-222-1222. Link
- 42 CFR § 423.600(a): request for IRE reconsideration within 60 calendar days. Electronic Code of Federal Regulations, current version. Link
- CMS. Tips for understanding your drug coverage and prescriptions (drug lists and tiers). Publication No. 12206, revised November 2023. Link
Last checked Oct 14, 2026 · Next review due Jan 14, 2027 · Report an error
How this page was made. Written by the GLP Guidebook team from the sources above. It’s general information, not medical advice. Talk to your doctor, pharmacist or prescriber before starting, stopping or changing any medicine. We don’t sell, prescribe or recommend any brand, plan or provider. How we write